Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
» WCRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

WCRX Guru Trades in Q1 2013

Diamond Hill Capital 943,104 sh (New)
Jim Simons 958,400 sh (New)
Joel Greenblatt 1,366,561 sh (New)
Louis Moore Bacon 800,000 sh (+24.63%)
RS Investment Management 7,647,542 sh (+7.22%)
John Keeley Sold Out
Steven Cohen 4,532,935 sh (-31.79%)
Private Capital 1,524,105 sh (-32.71%)
Paul Tudor Jones 25,000 sh (-56.97%)
» More
Q2 2013

WCRX Guru Trades in Q2 2013

Pioneer Investments 242,800 sh (New)
Mario Gabelli 16,500 sh (New)
Jim Simons 2,893,400 sh (+201.9%)
Diamond Hill Capital 1,418,393 sh (+50.4%)
Private Capital 1,550,780 sh (+1.75%)
Louis Moore Bacon 300,000 sh (unchged)
Louis Moore Bacon Sold Out
Stanley Druckenmiller Sold Out
Joel Greenblatt 1,224,629 sh (-10.39%)
RS Investment Management 5,331,335 sh (-30.29%)
Paul Tudor Jones 12,900 sh (-48.4%)
Steven Cohen 438,812 sh (-90.32%)
» More
Q3 2013

WCRX Guru Trades in Q3 2013

Jeremy Grantham 103,693 sh (New)
Jim Simons 4,617,505 sh (+59.59%)
Private Capital 1,572,147 sh (+1.38%)
Pioneer Investments 242,800 sh (unchged)
Paul Tudor Jones Sold Out
Mario Gabelli Sold Out
RS Investment Management 5,302,224 sh (-0.55%)
Steven Cohen 431,112 sh (-1.75%)
Joel Greenblatt 1,026,192 sh (-16.2%)
Diamond Hill Capital 704,340 sh (-50.34%)
» More
Q4 2013

WCRX Guru Trades in Q4 2013

Pioneer Investments Sold Out
Jim Simons Sold Out
Joel Greenblatt Sold Out
Steven Cohen Sold Out
Diamond Hill Capital Sold Out
Jeremy Grantham Sold Out
Private Capital Sold Out
RS Investment Management Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with WCRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-09-30 Reduce -16.2%0.16%$19.36 - $22.27 $ 22.939%1026192
Mario Gabelli 2013-09-30 Sold Out $19.36 - $22.27 $ 22.939%0
Mario Gabelli 2013-06-30 New Buy$13.4 - $20.61 $ 22.9335%16500
Joel Greenblatt 2013-03-31 New Buy0.94%$12.04 - $14.59 $ 22.9369%1366561
John Keeley 2013-03-31 Sold Out 0.0031%$12.04 - $14.59 $ 22.9369%0
Vanguard Health Care Fund 2012-06-30 Sold Out 0.04%$15.29 - $21.93 $ 22.9323%0
Joel Greenblatt 2012-03-31 Sold Out 0.18%$15.74 - $17.47 $ 22.9347%0
Vanguard Health Care Fund 2012-03-31 Add 129.2%0.02%$15.74 - $17.47 $ 22.9347%532200
Joel Greenblatt 2011-12-31 Add 256.19%0.13%$13.33 - $18.68 $ 22.9343%96812
Joel Greenblatt 2011-09-30 Reduce -53.17%0.1%$13.67 - $24.62 $ 22.9323%27180
Joel Greenblatt 2011-06-30 New Buy0.2%$22.19 - $25.73 $ 22.93-3%58040
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Specialty & Generic
Compare:TKPYY, TEVA, AGN, FRX, MRX » details
Traded in other countries:G3LA.Germany
Warner Chilcott Limited was formed through a series of acquisitions and divestitures. It began commercial operations on January 5, 2005 when it acquired Warner Chilcott PLC ("Predecessor"). Its Predecessor was incorporated in 1968 as a sales and marketing organization focused on branded pharmaceutical products in Northern Ireland, but in September 2000 expanded into the U.S. pharmaceuticals market through the acquisition of a U.S. pharmaceutical business that marketed a portfolio of products including OVCON and ESTRACE Cream. It is a global pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. The Company is a fully integrated company with internal resources dedicated to the development, manufacture and promotion of its products. It markets and sells the following principal products: Gastroenterology, Women's Healthcare, Dermatology and Urology. The Company markets its products mainly to physicians and employs marketing techniques to identify and target physicians with the highest potential to prescribe its products. Its branded products compete with brands marketed by other pharmaceutical companies including large, fully integrated concerns with financial, marketing, legal and product development resources greater than theirs. The U.S. pharmaceutical industry is subject to regulation by national, regional, state and local agencies.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide